These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7769587)

  • 1. Two macroprolactinomas presenting with neurological signs.
    Khan EG; Howlett TA
    J R Soc Med; 1995 Feb; 88(2):111P-112P. PubMed ID: 7769587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chiasmal herniation as a complication of bromocriptine therapy.
    Taxel P; Waitzman DM; Harrington JF; Fagan RH; Rothfield NF; Chen HH; Malchoff CD
    J Neuroophthalmol; 1996 Dec; 16(4):252-7. PubMed ID: 8956160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Her vision was tied down.
    Dorotheo EU; Tang RA; Bahrani HM; Schiffman JS; Bhatti MT; Lewis SB
    Surv Ophthalmol; 2005; 50(6):588-97. PubMed ID: 16263371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and optic chiasmal herniation following cabergoline treatment for a giant prolactinoma: wait or intervene?
    Papanastasiou L; Fountoulakis S; Pappa T; Liberopoulos K; Malliopoulos D; Markou A; Piaditis G
    Hormones (Athens); 2014; 13(2):290-5. PubMed ID: 24776630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endonasal endoscopic transsphenoidal chiasmapexy using a clival cranial base cranioplasty for visual loss from massive empty sella following macroprolactinoma treatment with bromocriptine: case report.
    Alvarez Berastegui GR; Raza SM; Anand VK; Schwartz TH
    J Neurosurg; 2016 Apr; 124(4):1025-31. PubMed ID: 26339851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rapid resolution of visual abnormalities with medical therapy alone in patients with large prolactinomas.
    Mbanya JC; Mendelow AD; Crawford PJ; Hall K; Dewar JH; Kendall-Taylor P
    Br J Neurosurg; 1993; 7(5):519-27. PubMed ID: 8267889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Visual function improvement in patients with macroprolactinomas treated with bromocriptine.
    Lesser RL; Zheutlin JD; Boghen D; Odel JG; Robbins RJ
    Am J Ophthalmol; 1990 May; 109(5):535-43. PubMed ID: 2333917
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amyotrophic lateral sclerosis and prolactinoma.
    Kararizou E; Stamboulis E; Markou I; Alevizaki M; Gkiatas K
    Funct Neurol; 2007; 22(1):39-41. PubMed ID: 17509242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth of prolactinoma despite lowering of serum prolactin by bromocriptine.
    Kupersmith MJ; Kleinberg D; Warren FA; Budzilovitch G; Cooper P
    Neurosurgery; 1989 Mar; 24(3):417-23. PubMed ID: 2927618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid rhinorrhea occurring in long-term bromocriptine treatment for macroprolactinomas.
    Eljamel MS; Foy PM; Swift AC; MacFarlane IA
    Surg Neurol; 1992 Oct; 38(4):321. PubMed ID: 1440226
    [No Abstract]   [Full Text] [Related]  

  • 11. Campimetric alterations caused by pituitary microadenoma successfully treated by transsphenoidal adenomectomy.
    Madrazo-Navarro I; Maldonado-León JA
    Arch Invest Med (Mex); 1991; 22(1):9-12. PubMed ID: 1819982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macroprolactinomas as cause of delayed puberty. A report of two cases and effects of medical therapy.
    Minniti G; Jaffrain-Rea ML; Ferretti E; Gulino A; Tamburrano G
    Minerva Endocrinol; 1996 Jun; 21(2):67-71. PubMed ID: 8968149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Giant prolactinomas in men: efficacy of cabergoline treatment.
    Corsello SM; Ubertini G; Altomare M; Lovicu RM; Migneco MG; Rota CA; Colosimo C
    Clin Endocrinol (Oxf); 2003 May; 58(5):662-70. PubMed ID: 12699451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-acting and repeatable dose bromocriptine in the prolonged treatment of prolactinoma].
    Pereira JL; García-Luna PP; Leal-Cerro A; Cortés A; Trujillo F; Villamil F; Vaquero F; Revuelta M; Astorga R
    Med Clin (Barc); 1994 Jun; 103(2):59-64. PubMed ID: 8051973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fifteen-Year-Old Female With Delayed Progression of Puberty and Visual Disturbances.
    Akhtar S; Patel L; Bakhach M; Haider A; Gonzalez-Martinez J; Rogers D; Tsilianidis L; Raissouni N; Schweiger M
    Clin Pediatr (Phila); 2016 Jun; 55(7):664-7. PubMed ID: 26581351
    [No Abstract]   [Full Text] [Related]  

  • 16. [Do articular manifestations appear in prolactinomas?].
    Bauduceau B; Eulry F; Mayaudon H; Ducorps M; Helie C; Riveline JP
    Presse Med; 1995 Apr; 24(14):695. PubMed ID: 7770420
    [No Abstract]   [Full Text] [Related]  

  • 17. Optic chiasmal herniation--an under recognized complication of dopamine agonist therapy for macroprolactinoma.
    Jones SE; James RA; Hall K; Kendall-Taylor P
    Clin Endocrinol (Oxf); 2000 Oct; 53(4):529-34. PubMed ID: 11012580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolactinomas and the eye: a clinical case and review.
    Sink M; Chou J
    Optom Vis Sci; 2012 Nov; 89(11):e85-94. PubMed ID: 23034337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral inferior hemifield visual loss secondary to a pituitary prolactinoma.
    Batra R; Toogood A; Jacks AS
    Can J Ophthalmol; 2017 Dec; 52(6):e220-e225. PubMed ID: 29217048
    [No Abstract]   [Full Text] [Related]  

  • 20. A developing visual field defect.
    Larner AJ
    Postgrad Med J; 2002 Feb; 78(916):106, 112-3. PubMed ID: 11807202
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.